403 ERROR
The request could not be satisfied.
Request blocked. We can't connect to the server for this app or website at this time. There might be too much traffic or a configuration error. Try again later, or contact the app or website owner.
If you provide content to customers through CloudFront, you can find steps to troubleshoot and help prevent this error by reviewing the CloudFront documentation.
Generated by cloudfront (CloudFront) Request ID: 1YXD7c81pOEndMIFgXWLa9SFkJeAmfBTHPWkJoxexKdWLmiM5CVvFA==
"I guess I'm just gonna chart a new path, and kinda get a frontier mentality. Everything's a blur, so I'm just gonna rewrite it." —— Taylor Swift
Internet + MicroDetect Medical Platform
BUCT-China 2024 aims to establish an internet-based cancer detection platform—“Internet + MicroDetect Medical Platform”—and provide an integrated user-friendly home testing kit. This platform enables users to self-sample, send back samples, and receive professional testing guidance and quick result feedback via an app. Furthermore, by using reagent pre-mixing, we streamline the process, reduce contamination risks, and achieve a turnaround time of under 60 minutes from sample handling to app display of results. The cost of our single test service is approximately $20, which offers a significant advantage over traditional cancer detection methods that rely on large equipment and surgical procedures, making high-quality testing services more affordable and promoting healthcare equity.
BUCT-China 2024 aims to establish an internet-based cancer detection platform—“Internet + MicroDetect Medical Platform”—and provide an integrated user-friendly home testing kit. This platform enables users to self-sample, send back samples, and receive professional testing guidance and quick result feedback via an app. Furthermore, by using reagent pre-mixing, we streamline the process, reduce contamination risks, and achieve a turnaround time of under 60 minutes from sample handling to app display of results. The cost of our single test service is approximately $20, which offers a significant advantage over traditional cancer detection methods that rely on large equipment and surgical procedures, making high-quality testing services more affordable and promoting healthcare equity.